An analyst's downbeat new take on Summit Therapeutics (SMMT -11.32%) pushed its stock downward on Hump Day. At the end of Wednesday, the shares had booked a loss of over 11% in price as investors absorbed the negative take. That was a far steeper fall than the 0.3% slide of the S&P 500 (^GSPC -0.27%) that trading session.Bearish on SummitWell before market open that day, Leerink Partners' Daina Graybosch initiated coverage on Summit stock. This wasn't a positive appraisal, as the analyst flagged it with an ...

Meta has reportedly poached some top engineers from tech firms for its artificial general intelligence (AGI) team.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.One engineer who confirmed he is moving to Meta is J ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

On news of a fresh contract signing with a branch of the U.S. military, investors piled into the stock of nuclear energy start-up Oklo (OKLO 29.48%) on Wednesday. That surge in interest blasted the stock higher by almost 30%, on a day when the S&P 500 index dipped by 0.3%.Going nuclearWednesday morning Oklo announced, no doubt with great pleasure, that it had received a notice of intent to award (NOITA) for a project in Alaska. The company was notified by the government's Defense Logistics Agency on behalf ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

JPMorgan Chase CEO Jamie Dimon issued a new warning about the U.S. economy, saying that conditions could deteriorate soon and undermine a potential soft landing. "I think there's a chance real numbers will deteriorate soon," Dimon said Tuesday at a Morgan Stanley conference.Dimon pushed back on suggestions that economic surveys showing diminished business and consumer confidence are an indicator of what's to come. He explained that "neither consumers nor businesses ever pick the inflection points," and adde ...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Inflection Point Acquisition Corp. III (Nasdaq: IPCXU) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their overallotment option, completed on April 28, 2025 (the “Offering”) may elect to separately trade the Class A ordinary shares and rights included in the units commencing on or about June 16, 2025. Any un ...

Here's our initial take on Oracle's (ORCL -0.64%) fiscal 2025 fourth-quarter financial report.Key MetricsMetricQ4 FY24Q4 FY25Changevs. ExpectationsRevenue$14.3 billion$15.9 billion+11%BeatEarnings per share (adjusted)$1.63$1.70+4%BeatCloud infrastructure revenue$2.0 billion$3.0 billion+52%n/aCloud application revenue$3.3 billion$3.7 billion+12%n/aCloud Infrastructure SoarsOracle's cloud infrastructure revenue rose by 52% year over year in the fourth quarter of fiscal 2025 to $3.0 billion, and the company se ...

Conventional investor wisdom holds that the consumer discretionary sector performs best when the economy is thriving and customers have money to spend. Low interest rates and strong job growth may be other important indicators of a potential boom in consumer discretionary companies. With those things in mind, investors might expect that stocks in the consumer discretionary sector would be a non-starter in mid-2025. After all, a recent employment situation report from the U.S. Bureau of Labor Statistics show ...

Equinox Gold Provides Updated 2025 Gold Production and Cost Guidance, 2025 Full-year Pro Forma Guidance, Including Calibre Mining Assets, of 785,000 - 915,000 Ounces of Gold, Greenstone Mine Expecting Strong H2 2025June 11, 2025 5:07 PM EDT | Source: Equinox Gold Corp.Vancouver, British Columbia--(Newsfile Corp. - June 11, 2025) - Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) ("Equinox Gold" or the "Company") is updating its 2025 production and cost guidance to reflect the business combin ...